Refine by
Parkinsons Disease Suppliers & Manufacturers
92 companies found
based inAndernach, GERMANY
Since 1984 we have been focused on utilizing our expertise, experience and innovation to create market leading drug delivery solutions for our pharmaceutical partners. As a trusted technology partner for the pharmaceutical industry, we develop and ...
The TTS innovations accommodate individual market positioning and lifecycle management of established products. They are well-suited for patients with special needs, including those with Parkinson’s disease, and are ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inVictoria, BRITISH COLUMBIA (CANADA)
Established in 2007, StressMarq Biosciences is a bioreagents company producing high quality, cutting edge research products for the life sciences and drug discovery/biopharma markets. StressMarq is a market leader in the development and ...
based inSarasota, FLORIDA (USA)
We designed eVO to help patients, their families and healthcare providers gain more satisfactory and successful outcomes. eVO is the only motorized dual-motion therapy system with reciprocating handlebars and foot pedals interlinked to provide ...
based inLondon, UNITED KINGDOM
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. Colostrinin™ is promoted as having utility as a support for healthy brain ageing and cognition. ...
The complex and the peptides within it are viewed as having potential utility in neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s Disease, Multiple Sclerosis and ...
based inSeraing, BELGIUM
Eurogentec is a biotechnology company providing life science products and personalized services to academic, medical and industrial scientists world-wide. We are also a trusted CDMO internationally recognized for the development and production of ...
α-Synuclein is a major component of Lewy bodies in the affected neurons in Parkinson's disease. This protein has a mass of 14.5 kDa (140 amino acids long) and consists of a conserved degenerative ...
based inOttawa, ONTARIO (CANADA)
We are a Canadian medical device manufacturer providing unique and effective products for clients requiring therapy to combat the effects of limited mobility. Our Vision is to be the world leader in providing clients and their care givers access to ...
based inTaipei, TAIWAN
APrevent is a medical device company, founded in 2013 by a team of international clinically experienced physicians and engineers. APrevent's products improve voice and communication, focusing on the development of a long- term implant system and ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
expression cortical neurons and can be used for the research of neurological disorders, including epilepsy and parkinson's disease, et ...
based inMoscow, RUSSIA
Since 2009, our company develops and manufactures equipment for medical rehabilitation and diagnostics uses in health care and sports. Nowadays we are manufacturing the full range of neurophysiological devices and systems, namely Nevropolygraph ...
based inSouth San Francisco, CALIFORNIA (USA)
We are building the next enduring biotechnology company of the digital age. Verge has pioneered the industry's most advanced all-in-human, artificial intelligence powered drug discovery platform to unlock new drugs at scale for the biggest medical ...
based inMechanicsburg, PENNSYLVANIA (USA)
Originally founded in 2002 by Jose Dominguez, PT, MS, ATC as Cumberland Orthopedic and Spine Physical Therapy (and briefly as Elite Therapy and Fitness), FYZICAL Mechanicsburg located in Mechanicsburg, PA continues to operate under his ownership as ...
based inBrooklyn, NEW YORK (USA)
Synchron, an endovascular brain interface company, is a leader in implantable neural interface technology. The clinical-stage company is developing a neuroprosthesis for the treatment of paralysis and the first endovascular implantable ...
based inCambridge, MASSACHUSETTS (USA)
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition. Until recently, scientists believed that mature adult cells were permanently locked into their ...
based inBethesda, MARYLAND (USA)
Gain Therapeutics is redefining drug discovery with its SEE-Txâ„¢ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for ...
Parkinson’s disease is a neurodegenerative disorder that affects more than 6 million people worldwide. In most cases, the exact cause of Parkinson’s disease is unknown; ...
based inBaltimore, MARYLAND (USA)
Robin Medical, Inc., (Baltimore, MD) is a research and development company founded in 1997 by a group of physicians and engineers from the Johns Hopkins Hospital, aiming to translate various technologies investigated by the founders into clinical ...
based inNew York City, NEW YORK (USA)
Lauren Sciences is a privately-held New York biotechnology company focused on developing its V-Smart platform to create a robust pipeline of V-Smart therapeutics consisting of central nervous system (CNS)-active drugs that normally do not cross the ...
based inDavis, CALIFORNIA (USA)
For over fifty years, the people of Antibodies Incorporated have dedicated themselves to supporting the life-enhancing, breakthrough work of scientists everywhere. We fulfill our mission with an extensive catalog of validated neuroscience antibodies ...
based inEdinburgh, UNITED KINGDOM
Manus Neurodynamica is revolutionising health care management by developing and patenting neuroscience technologies that record recognised biomarkers of neuromotor impairments which can radically improve patient diagnosis and disease monitoring. Our ...
Motion features are translated into biomarkers to provide objective information about movement abnormalities which support diagnosis and monitoring of Parkinson's disease and other impairments. Full audit trail of ...
based inWendelsheim, GERMANY
MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics with the right diagnostic tools. Our first objective is to demonstrate clinical proof-of-concept with our lead compound ...
Parkinson's disease (PD) is one of the most common diseases of the central nervous system. It is usually diagnosed between the ages of 50 and 79, with increasing incidences at an advanced age; men ...
